ODC1 and leukemia: Such an effect was previously described by J. Janne’s group, which raised DFMO-resistant human and murine leukaemia cell lines by maintaining cells in the presence of subtoxic drug concentrations and then observed either multiplication of the ODC1 gene or its enhanced transcription [75].